Drugs / Benepali
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Benepali | — | 2016-01-13 | europa.eu ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03813771 | Mar 2019 → Feb 2023 | rheumatoid arthritis | University of Leeds | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Benepali | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03813771 ↗ |
| Route | Subcutaneous | “adminstered subcutaneously” NCT03813771 ↗ |